Literature DB >> 21281324

Risk of preterm delivery and hypertensive disorders of pregnancy in relation to maternal co-morbid mood and migraine disorders during pregnancy.

Swee May Cripe1, Ihunnaya O Frederick, Chunfang Qiu, Michelle A Williams.   

Abstract

We evaluated the risks of preterm delivery and hypertensive disorders of pregnancy among pregnant women with mood and migraine disorders, using a cohort study of 3432 pregnant women. Maternal pre-pregnancy or early pregnancy (<20 weeks gestation) mood disorder and pre-pregnancy migraine diagnoses were ascertained from interview and medical record review. We fitted generalised linear models to derive risk ratios (RR) and 95% confidence intervals (CI) of preterm delivery and hypertensive disorders of pregnancy for women with isolated mood, isolated migraine and co-morbid mood-migraine disorders, respectively. Reported RR were adjusted for maternal age, race/ethnicity, marital status, parity, smoking status, chronic hypertension or pre-existing diabetes mellitus, and pre-pregnancy body mass index. Women without mood or migraine disorders were defined as the reference group. The risks for preterm delivery and hypertensive disorders of pregnancy were more consistently elevated among women with co-morbid mood-migraine disorders than among women with isolated mood or migraine disorder. Women with co-morbid disorders were almost twice as likely to deliver preterm (adjusted RR=1.87, 95% CI 1.05, 3.34) compared with the reference group. There was no clear evidence of increased risks of preterm delivery and its subtypes with isolated migraine disorder. Women with mood disorder had elevated risks of pre-eclampsia (adjusted RR=3.57, 95% CI 1.83, 6.99). Our results suggest an association between isolated migraine disorder and pregnancy-induced hypertension (adjusted RR=1.42, 95% CI 1.00, 2.01). This is the first study examining perinatal outcomes in women with co-morbid mood-migraine disorders. Pregnant women with a history of migraine may benefit from screening for depression during prenatal care and vigilant monitoring, especially for women with co-morbid mood and migraine disorders.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21281324      PMCID: PMC3756187          DOI: 10.1111/j.1365-3016.2010.01182.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  31 in total

Review 1.  Stress and preterm birth: neuroendocrine, immune/inflammatory, and vascular mechanisms.

Authors:  P D Wadhwa; J F Culhane; V Rauh; S S Barve
Journal:  Matern Child Health J       Date:  2001-06

2.  The triad of substance abuse, violence, and depression are interrelated in pregnancy.

Authors:  T J Horrigan; A V Schroeder; R M Schaffer
Journal:  J Subst Abuse Treat       Date:  2000-01

3.  Preterm birth: associated neuroendocrine, medical, and behavioral risk factors.

Authors:  K Erickson; P Thorsen; G Chrousos; D E Grigoriadis; O Khongsaly; J McGregor; J Schulkin
Journal:  J Clin Endocrinol Metab       Date:  2001-06       Impact factor: 5.958

4.  Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women.

Authors:  S Hoffman; M C Hatch
Journal:  Health Psychol       Date:  2000-11       Impact factor: 4.267

5.  The impact of prenatal maternal stress and optimistic disposition on birth outcomes in medically high-risk women.

Authors:  M Lobel; C J DeVincent; A Kaminer; B A Meyer
Journal:  Health Psychol       Date:  2000-11       Impact factor: 4.267

6.  Assessment of the hypothalamic-pituitary-adrenal axis over a 24-hour diurnal period and in response to neuroendocrine challenges in women with and without childhood sexual abuse and posttraumatic stress disorder.

Authors:  J Douglas Bremner; Meena Vythilingam; George Anderson; Eric Vermetten; Thomas McGlashan; George Heninger; Ann Rasmusson; Steven M Southwick; Dennis S Charney
Journal:  Biol Psychiatry       Date:  2003-10-01       Impact factor: 13.382

7.  Depressive symptoms and migraine comorbidity among pregnant Peruvian women.

Authors:  Swee May Cripe; Sixto Sanchez; Nelly Lam; Elena Sanchez; Nely Ojeda; Silvia Tacuri; Carmen Segura; Michelle A Williams
Journal:  J Affect Disord       Date:  2009-08-20       Impact factor: 4.839

Review 8.  Prevalence of depression during pregnancy: systematic review.

Authors:  Heather A Bennett; Adrienne Einarson; Anna Taddio; Gideon Koren; Thomas R Einarson
Journal:  Obstet Gynecol       Date:  2004-04       Impact factor: 7.661

9.  A prospective study of maternal serum C-reactive protein concentrations and risk of preeclampsia.

Authors:  Chunfang Qiu; David A Luthy; Cuilin Zhang; Scott W Walsh; Wendy M Leisenring; Michelle A Williams
Journal:  Am J Hypertens       Date:  2004-02       Impact factor: 2.689

10.  The association between major depression and levels of soluble intercellular adhesion molecule 1, interleukin-6, and C-reactive protein in patients with recent acute coronary syndromes.

Authors:  François Lespérance; Nancy Frasure-Smith; Pierre Théroux; Michael Irwin
Journal:  Am J Psychiatry       Date:  2004-02       Impact factor: 18.112

View more
  28 in total

1.  Sleep disturbances among pregnant women with history of migraines: A cross-sectional study.

Authors:  Chunfang Qiu; Ihunnaya O Frederick; Tanya Sorensen; Sheena K Aurora; Bizu Gelaye; Daniel A Enquobahrie; Michelle A Williams
Journal:  Cephalalgia       Date:  2015-01-29       Impact factor: 6.292

Review 2.  Antidepressant use in pregnancy: a critical review focused on risks and controversies.

Authors:  N Byatt; K M Deligiannidis; M P Freeman
Journal:  Acta Psychiatr Scand       Date:  2012-12-14       Impact factor: 6.392

3.  Childhood Abuse, Intimate Partner Violence and Risk of Migraine Among Pregnant Women: An Epidemiologic Study.

Authors:  Bizu Gelaye; Ngan Do; Samantha Avila; Juan Carlos Velez; Qiu-Yue Zhong; Sixto E Sanchez; B Lee Peterlin; Michelle A Williams
Journal:  Headache       Date:  2016-05-31       Impact factor: 5.887

4.  Association between pre-pregnancy depression/anxiety symptoms and hypertensive disorders of pregnancy.

Authors:  Madhavi K Thombre; Nicole M Talge; Claudia Holzman
Journal:  J Womens Health (Larchmt)       Date:  2015-01-14       Impact factor: 2.681

5.  Depression and anxiety among high-risk obstetric inpatients.

Authors:  Nancy Byatt; Katherine Hicks-Courant; Autumn Davidson; Ruth Levesque; Eric Mick; Jeroan Allison; Tiffany A Moore Simas
Journal:  Gen Hosp Psychiatry       Date:  2014-07-27       Impact factor: 3.238

6.  Potential for prenatal yoga to serve as an intervention to treat depression during pregnancy.

Authors:  Cynthia L Battle; Lisa A Uebelacker; Susanna R Magee; Kaeli A Sutton; Ivan W Miller
Journal:  Womens Health Issues       Date:  2015 Mar-Apr

7.  Effect of maternal chronic disease on obstetric complications in twin pregnancies in a United States cohort.

Authors:  Emily Werder; Pauline Mendola; Tuija Männistö; Jennifer O'Loughlin; S Katherine Laughon
Journal:  Fertil Steril       Date:  2013-03-29       Impact factor: 7.329

8.  Triptan safety during pregnancy: a Norwegian population registry study.

Authors:  Kateřina Nezvalová-Henriksen; Olav Spigset; Hedvig Nordeng
Journal:  Eur J Epidemiol       Date:  2013-07-25       Impact factor: 8.082

Review 9.  Complementary and alternative medicine therapies for perinatal depression.

Authors:  Kristina M Deligiannidis; Marlene P Freeman
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2013-08-26       Impact factor: 5.237

10.  Antidepressant use and risk for preeclampsia.

Authors:  Kristin Palmsten; Krista F Huybrechts; Karin B Michels; Paige L Williams; Helen Mogun; Soko Setoguchi; Sonia Hernández-Díaz
Journal:  Epidemiology       Date:  2013-09       Impact factor: 4.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.